Senetek PLC Release: New PyratineXR(TM) Offers Hope for 14 Million-Plus Rosacea Sufferers and Others with Facial Redness

Published: Jul 22, 2009

NAPA, Calif., July 22 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY - News), a Life Sciences company engaged in the research, development and commercialization of technologies that target the science of healthy aging, today announced that PyratineXR, the company's next generation of Cytokinin-based skincare technology, is now available nationwide through select dermatologists and other physicians who comprise the PyratineXR Physicians Network. The national launch comes just months after Senetek unveiled PyratineXR at the American Academy of Dermatology's 67th Annual Meeting in March. The launch will be supported by both conventional and new line media advertising which will be appearing in select markets nationwide in August. To view copies of the ads, please visit http://www.senetekplc.com/ads.

Back to news